According to the GuruFocus All-in-One Guru Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the past 12 months and were bought by gurus during the last quarter.
Bio-Rad Laboratories Inc. (BIO, Financial) has a market cap of $8.95 billion. It has outperformed the S&P 500 Index by 15.8% over the past 12 months.
The stock is trading with a price-book ratio of 2. According to the discounted cash flow calculator, the stock is overpriced by 11% at $301 per share. The stock price is currently 44.05% above its 52-week low and 0.19% below its 52-week high.
The company manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and health care companies. It has a profitability and growth rating of 6 out of 10. Its return on equity of 24.28% and return on assets of 16.83% are outperforming 61% of other companies in the Global Diagnostics & Research industry. Its financial strength is rated 8 out of 10. The cash-debt ratio of 1.77 is below the industry median of 3.52.
The company’s largest shareholder among the gurus is Jim Simons (Trades, Portfolio) with 1.15% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.89% and John Rogers (Trades, Portfolio) with 0.84%.
With a market cap of $12.17 billion, Black Knight Inc. (BKI, Financial) has outperformed the S&P 500 Index by 18.7% over the past 12 months.
The stock is trading with a price-book ratio of 4.75. According to the DCF calculator, the stock is overpriced by 209% at $51.95 per share. The stock price is currently 37.25% above its 52-week low and 1.98% below its 52- week high.
The company, which provides software, data and analytics solutions, has a profitability and growth rating of 6 out of 10. Its return on equity of 15.81% and return on assets of 5.75% are outperforming 60% of other companies in the Global Software – Infrastructure industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 0.01 is below the industry median of 8.37.
Daniel Loeb (Trades, Portfolio) is the largest shareholder of the company among the gurus with 0.84% of outstanding shares, followed by Columbia Wanger (Trades, Portfolio) with 0.29% and Simons with 0.19%.
BlackRock Inc. (BLK, Financial) has a market cap of $88.47 billion. It has outperformed the S&P 500 Index by 17.2% over the past 12 months.
The stock is trading with a price-book ratio of 2.77. According to the DCF calculator, the stock is undervalued with a 24% margin of safety at $549.06 per share. The stock price is currently 34.37% above its 52-week low and 7.65% below its 52-week high.
The investment management company has a profitability and growth rating of 9 out of 10. While its return on equity of 17.03% is outperforming the sector, its return on assets of 2.35% is underperforming 57% of other companies in the Global Asset Management industry. Its financial strength is rated 5 out of 10 with a cash-debt ratio of 1.21.
The company’s largest guru shareholder is Loeb with 0.68% of outstanding shares, followed by Steve Mandel (Trades, Portfolio) with 0.57% and Pioneer Investments (Trades, Portfolio) with 0.28%.
With a market cap of $5.04 billion, Blackbaud Inc. (BLKB, Financial) has outperformed the S&P 500 Index by 17.2% over the past 12 months.
The stock is trading with a price-book ratio of 14.63. According to the DCF calculator, the stock is overpriced by 547% at $103.81 per share. The stock price is currently 27.16% above its 52-week low and 10.56% below its 52-week high.
The company, which provides cloud software and other related services, has a profitability and growth rating of 8 out of 10. Its return on equity of 25.09% and return on assets of 5.37% are outperforming 60% of other companies in the Global Software - Application industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.05 is below the industry median of 8.37.
Simons is the company's largest guru shareholder with 0.41% of outstanding shares, followed by Pioneer Investments with 0.16% and Caxton Associates (Trades, Portfolio) with 0.01%.
Bluebird Bio Inc. (BLUE, Financial) has a market cap of $9.02 billion. It has outperformed the S&P 500 Index by 44.2% over the past 12 months.
The stock is trading with a price-book ratio of 5.73. The stock price is currently 110.04% above its 52-week low and 23.83% below its 52-week high.
The company develops therapies for severe genetic and rare diseases. It has a profitability and growth rating of 2 out of 10. Its return on equity of -30.08% and return on assets of -24.80% are outperforming 56% of other companies in the Global Biotechnology industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 7.21 is below the industry median of 73.06.
With 0.65% of outstanding shares, the Vanguard Health Care Fund (Trades, Portfolio) has the largest position, followed by Simons with 0.2%, Steven Cohen (Trades, Portfolio) with 0.01% and Joel Greenblatt (Trades, Portfolio) with 0.01%.
With a market cap of $6.76 billion, BOK Financial Corp. (BOKF, Financial) has outperformed the S&P 500 Index by 6.8% over the past 12 months.
The stock is trading with a price-book ratio of 1.94. According to the DCF calculator, the stock is overpriced by 77% at $103.3 per share. The stock price is currently 33.98% above its 52-week low and 3.46% below its 52-week high.
The bank holding company has a profitability and growth rating of 3 out of 10. Its return on equity of 10.10% and return on assets of 1.08% are outperforming 61% of other companies in the Global Banks - Regional - U.S. industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.44 is below the industry median of 2.12.
Diamond Hill Capital (Trades, Portfolio) is the company's largest guru shareholder with 1.24% of outstanding shares, followed by Rogers with 0.79%, Chuck Royce (Trades, Portfolio) with 0.75% and Columbia Wanger (Trades, Portfolio) with 0.38%.
Disclosure: I do not own any stocks mentioned in this article.
